14 November 2024
YOUNG & CO.’S BREWERY, P.L.C. INTERIM RESULTS FOR THE 26 WEEKS ENDED 30 SEPTEMBER 2024 STRONG PROFIT PERFORMANCE SUPPORTED BY CITY PUBS INTEGRATION 2024…
Blenrep shows overall survival benefit in head-to-head DREAMM-7 phase III trial for relapsed/refractory multiple myeloma · Statistically significant and clinically meaningful reduction in the risk of…
13 November 2024
13 NOVEMBER 2024 FULLER, SMITH & TURNER P.L.C. (“Fuller’s”, the “Company”, or the “Group”) Financial results for the 26 weeks to 28 September 2024…
8 November 2024
Tezspire met both co-primary endpoints in the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps Tezspire demonstrated a statistically significant and…
7 November 2024
John Pettigrew, Chief Executive, said: “Over the last six months, the exciting momentum within National Grid has continued as we deliver an unprecedented step…
6 November 2024
Annual Report and Financial Statements 31 August 2024 As at 31 August 2024 As at 31 August 2023 Net assets (£’000)1 640,300…
Dotdigital Group plc (“Dotdigital”, the “Company”, or the “Group”) Full Year Results Enhanced technology platform paving the way for higher value opportunities Dotdigital Group plc (AIM:…
31 October 2024
SUMMARY OF UNAUDITED RESULTS Quarters $ million Nine months Q3 2024 Q2 2024 Q3 2023 %¹ Reference 2024 2023 % 4,291 …